Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | (29.0%) | (3,216.2%) | (90.7%) | (2,246.9%) | (329.2%) | (261.3%) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Free Cash Flow margin is (243.5%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Free Cash Flow margin for Aadi Bioscience, Inc. have been (478.5%) over the past three years, and (61,063.3%) over the past five years.
As of today, Aadi Bioscience, Inc.'s Free Cash Flow margin is (243.5%), which is higher than industry median of (743.0%). It indicates that Aadi Bioscience, Inc.'s Free Cash Flow margin is Good.